Evofem Biosciences, Inc. (EVFM) stock
EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-10.00%)
Close on Oct 19, 2026Market cap $865.23KP/E –Yield –
Evofem Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Evofem Biosciences's price to sales ratio was 0.0× on Oct 19, 2026, against 0.1× a year earlier. Over the last 5 years it ranged from 0.0× to 14.5×, with a median of 0.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.0× | −0.0 |
| 2025 | Dec 31, 2025 | 0.1× | +0.0 |
| 2024 | Dec 31, 2024 | 0.1× | +0.0 |
| 2023 | Dec 29, 2023 | 0.0× | −0.3 |
| 2022 | Dec 30, 2022 | 0.3× | −11.7 |
| 2021 | Dec 31, 2021 | 12.1× | – |
See a number that looks wrong?